Search the webpage

Update on operations during COVID-19 period
Updated on May 21st, 2020

During recent weeks, we received many inquires regarding our operations during the coronavirus pandemic. Fortunately, both our primary sites are located in the Northern part of Europe and are fully operational. We have adopted additional safeguards to protect our personnel, including transitioning all non-research personal to telecommuting. 

As many universities across the United States and in some European and Asian countries are closed, we are aware of the difficulties this is placing on maintaining productivity on grant-funded projects. Therefore, we would like to remind our colleagues from academia that we are here for you to help! If you are interested in outsourcing your in vitro and in vivo studies, please get in touch with us and discuss an opportunity to advance your studies at Experimentica! We have special academic pricing in place to help you through this pandemic.

Experimentica Ltd. is a contract research organization (ophthalmic CRO) dedicated to developing and offering novel preclinical ocular models and services to clients in the pharmaceutical, biotech and academic sectors.

We offer the preclinical development pipeline with an industry leading portfolio of in vitro, ex vivo and in vivo models. Choose one of the categories below to learn more:



Refinement of the EAE Mouse Model

Experimental Autoimmune Encephalomyelitis (EAE) is used to study Multiple Sclerosis (MS) a chronic neuroinflammatory demyelinating disorder of the CNS. EAE ... Read More

A synthetic metalloporphyrin SOD mimetic protects corneal epithelial cells from oxidative stress-induced damage in vitro and in vivo

Keratoconjunctivitis sicca (KCS) is a multifactorial disease of the lacrimal glands and ocular surface1. Pathological findings in patients with KCS ... Read More

Bright light damage (BLD) model

Retinal damage induced by bright light (BLE) in laboratory rodents has remained one of the most widely used models mimicking ... Read More

Subscribe to Our Newsletter!

We promise that no sales pitches will be attached to newsletter. And don't worry, we hate spammers too!